ABSTRACT
There are clear legal and ethical requirements for informed consent in pediatric kidney transplantation. While much is done pre‐transplant to educate patients and families on the risks and benefits of transplantation and its associated medical therapies, it can be difficult to truly prepare them for the transformative nature of the transplant‐ how it will change their lives, their families' lives, and their view of themselves and their world. Using the lens of “transformative experiences” as described by philosopher L.A. Paul, we describe the transformative nature of pediatric kidney transplantation. We encourage the health care team to acknowledge this transformative experience, and outline practical strategies including shared decision making and patient and family engagement to help communicate with families undergoing this transformation, both before and after pediatric kidney transplantation.
Abbreviations
- KT
kidney transplant
- PFE
patient and family engagement
- SDM
shared decision making
1. Information Sharing and Decision Making in Pediatric Renal Transplant
Kidney transplant offers significant survival and quality of life advantages compared to dialysis, and remains the preferred treatment modality for children with end stage kidney disease [1, 2]. Decision making regarding transplant however, is complex and multifactorial. Patients and families considering transplant are provided with an abundance of information regarding pre‐transplant testing, donor type, wait‐listing, the surgical procedure and peri‐transplant care [3]. Families must also consider and temper expectations for post‐transplant life, and understand the continued need for intensive medical management and the possibility of post‐transplant complications such as rejection, malignancy, disease recurrence and need for re‐transplantation, among others [4]. All things considered, families of children eligible for kidney transplant have an enormous amount of information to process and a multitude of decisions to make. While the information is both necessary and valued, patients acknowledge that it can also be overwhelming [5]. Information processing is often limited by the ability of the patient or family to understand and weigh the risks and outcomes, and to choose among a host of non‐ideal but necessary options. Families have expressed feeling unprepared for reality after transplant, despite the informed consent conversations that occurred pre‐transplant [6].
Further, emotional and psychological influences may have an impact on the full comprehension of risks and benefits. Children themselves may have limited decision making capacity due to their illness, its associated co‐morbidities or their developmental status. Parents are asked to make these decisions at the same time that they are caring for sick children with chronic kidney disease, with its attendant emotional distress and instability [4]. After transplant families must then navigate immediate changes in the medical complexity and needs of their child's new condition, in ways in which pre‐discharge education and training may not entirely capture. Some parents may themselves be recovering from living donor surgery, or caring for a living donor family member in addition to their recipient child. This transition can impact the overall functioning, quality of life, and mental health of the child and family, and effects may persist years after transplant [7, 8]. Consent to transplant thus involves complex decision making at many points along the transplant journey, influenced by a number of emotional social factors, and medical considerations for their child.
2. Ethical and Legal Obligations for Informed Consent
Informed consent in pediatric transplantation is essential as it is both a legal and ethical imperative in all of medicine. The concept centers around respect for bodily integrity and autonomy and originated in relation to surgical procedures, which were sometimes unwarranted and often performed without prior discussion. In the modern American healthcare system the requirement has now expanded to include medical investigations, treatments and procedures of all sorts, except in the most emergent situations [9]. In the 1957 case Salgo v Leland Stanford Jr University Board of Trustees, the plaintiff Mr. Salgo sued the Stanford University Medical Center for improper disclosure of risk related to an imaging procedure. Here the court ruled, “…in discussing the element of risk a certain amount of discretion must be employed consistent with the full disclosure of facts necessary to an informed consent” [10]. Thus, the basic legal obligations of informed consent were established and its ethical imperative as a means of beneficence and patient autonomy, was born. Later, Canterbury v. Spence (1972) further defined and established what information in particular is to be included in the informed consent process and shifted the relative importance of information to the “reasonable patient” standard [11, pp. 157–166]. This emphasizes the patient's values and preferences in medical decision making over that of the physician's assessment of what their patient should need to know, effectively highlighting the ethical imperative of patient autonomy and self‐determination [12]. While relatively straightforward for many decisions (e.g., deciding between an open or laparoscopic approach to a needed appendectomy) this standard can become quite complex when the information encompasses both surgical and medical therapies, when both short and long term sequelae need to be considered, when prognoses are unclear and when patient and caregiver values and preferences are different from the clinician's or from each other. The default is generally to give more information, not less, but more information does not necessarily lead to better decisions and can, as demonstrated in the research ethics literature, often overwhelm decision makers [13].
In pediatrics, when children often lack the capacity to make their own medical decisions, parents are then designated the surrogate decision makers to make the decision with the best possible outcome for their children. Though this assessment of best outcomes is often a reflection of parental subjective values and preferences, parents do not have the same discretion that they would have for their own medical decisions. They are charged with deciding what is best for their child in a given circumstance, not necessarily what they would choose for themselves in a similar circumstance. They must be provided with sufficient information to make these decisions, as in adult decision making. However, information sharing in these situations can be complex, not only because of the complexity of the medical information itself, but because of unclear prognoses for many conditions and the emotional complexities of caring and making decisions for sick children.
While informed consent is both ethically desired and legally required, should we look differently at what we are trying to achieve when seeking informed consent for transplantation? Are there methods to properly prepare families for this journey while acknowledging how much we do not know and cannot predict?
3. The Transplant Experience
In addition to the specific medical, social and psychological considerations of transplant, the entire experience itself is transformative, as described by patients and families. “…But maybe one or two weeks after the operation, the transformation in X (the child), it was phenomenal”, one parent stated in a qualitative study that described how overall, kidney transplant was considered a turning point which led to transformation at the physical, mental, emotional and social level [14]. Another qualitative study investigating patients' “kidney identities” revealed several themes relating to the transformation of personal identity in transplant patients and caregivers [15].
Even when a patient or family does not utilize “transformational” terminology, described experiences of patients and families after renal transplant can be interpreted as that of a transformative experience. Families and patients have described adjusting to a “new normal” with transitions to complex regimens after transplant [16]. Some adolescents have described development of a new identity, to the point of having identity crises after transplant—“I don't really know what my personality is now. I used to be really shy but now I'm really outspoken…” [17]. Other families have described having a completely new life perspective after transplant, and view transplant as a “second chance” [18].
The importance of transplant as an experience has been emphasized by patients and families. In a qualitative study of pediatric transplant recipients, the children themselves expressed issues with the education they had received as being focused on the transplantation process but not including discussions of life with a transplant. These patients reported feeling unprepared in their experience after transplant [18]. Studies have also identified gaps in the understanding of patients and families with their post‐transplant experience. Caregivers have been struck with how burdensome frequent post‐transplant care can be, and others have expressed not truly grasping the reality of transplant as a treatment and not a cure [18, 19].
Given the numerous medical and surgical considerations of transplant, as well as the fact that transplant itself is a transformative experience in which the effect on identity cannot be predicted, how then can we properly discharge our duty to provide adequate information to patients and families in their transplant journey? How can we help them better understand and prepare for not only the medical needs, but also for life and its experience, after transplant. How can we continue to uphold the ethical principles—non‐maleficence, beneficence, autonomy—inherent in our discussion of informed consent for transplant?
4. Transformative Experiences
Philosopher L.A. Paul investigates this notion of “transformative experience” in her book of the same title. She first uses the radical (and obviously fictional) example of being offered the chance to become a vampire, trading mortality for eternal youth and a craving for human blood. She posits that since the lives before and after this decision are so extremely different that it is impossible to make a purely evidence‐based decision about whether or not to accept the vampire's bite. She follows with several more realistic examples of transformative experiences such as becoming a parent or restoring hearing via cochlear implants to explain how with some experiences, it is impossible to understand the post‐experience life until one has actually gone through the experience. Each of these experiences fall into two categories: epistemically transformative and personally transformative experiences. An epistemically transformative experience is the “kind that teaches someone something they could not have learned without having that kind of experience” [20, p. 15]. A personally transformative experience is that “sort of experience that can change who you are, in the sense of radically changing your view….” [20, p. 17]. These types of experiences can “change your subjective value for what it is like to be you, and change your core preferences about what matters” [20, p. 18].
When an experience falls into both categories, Paul classifies the experience as a truly transformative experience. It is these transformative experiences that are philosophically important as they raise unique problems for decision making. Paul argues that standard normative decision making may not apply to such transformative experiences since there is “ignorance about what it will be like to undergo the experience and ignorance about how the experience will change you” [20, p. 26]. Rational normative decision making requires an individual to evaluate subjective outcomes of different experiences and thus choose the experience that will most likely result in the preferred outcome. Normative decision making is thus the basis for informed consent. But how is this possible when (1) we know nothing about the experience itself and (2) we acknowledge that our subjective preferences and values may change after the experience? Paul argues we must, in these circumstances “reformulate the structure of the decision model” if we are to preserve authenticity and rationality [20, p. 79].
One means of restructuring the decision is to focus on the decision itself as the choice. Paul argues that you can solely focus on the decision of trying something new, or undergoing a transformative experience itself, rather than focus on the outcomes and how they fit current preferences. In other words, “you choose the experience for the sake of discovery itself, even if this entails a future that involves stress, suffering or pain” [20, p. 80–84]. While this may be less than satisfactory for some, Paul argues that in these extraordinary cases of transformative decisions, such as becoming a vampire, becoming a parent or undergoing a cochlear implant, we must embrace the fact that epistemically and personally, we have very little to go on [20, p. 85].
5. Supporting Familial Decision Making Throughout a Transformative Experience
As we've highlighted previously, kidney transplant is a transformative experience. Despite our best efforts at information sharing and informing decisions, for the family and patient undergoing transplant, the experience itself can be both epistemically and personally transformative. Thus, normative decision making and true informed consent can be difficult to navigate. A decision maker can and should be told that transplant improves survival and quality of life, and should be given information such as risks, benefits, complications. However, unless they already have lived experience with transplant, and even then since they have not had all the possible post‐transplant journeys themselves, they cannot truly understand the experience until they undergo the experience. For Paul, with first personal decision making “the implicit assumption of decision theory that, as long as we can describe the outcomes, we have the information we need to assign the relevant values and determine our preferences” fails [20, p. 78]. As clinicians, we therefore must recognize that limiting the pre‐transplant discussion to risks and benefits alone is a disservice to our patients and their families. If we accept that transplant is a transformative experience, we must then empower, support and appropriately counsel patients and families who have entered our exam room, are preparing to undergo this transformative experience, and who we ask to trust us to join them on their journey. See Table 1 for practical examples regarding the following recommendations.
TABLE 1.
Tips for acknowledging transplant as a transformative experience in the clinical space.
| Clinical stage | Epistemic humility | Practice points | Example language |
|---|---|---|---|
| Pre transplant | Acknowledge and appreciate the transformative nature of transplant |
|
“I know what it's like to be a pediatric nephrologist, and have been with many families on this journey, but I can't truly understand what it is like to be going through this as a patient/parent/family” |
| Understand that medical professionals have important knowledge to impart, but cannot fully understand, explain or predict life after transplant |
|
“While I have taken care of a lot of kids with kidney disease, and there is a lot of evidence to help guide us, every child's journey is different. Kidney transplant changes the lives of all children who go through this, but not always in the same ways” | |
| Communicate with families that transplant may be transformative |
|
“Life after transplant will be very different from your life now. Some things we will be able to predict, like the fact that you will be on different medications, have less dietary restrictions and will likely feel a lot better physically. Other things are more difficult to predict, like how you will feel about telling your friends what happened when you go back to school (for example). Sometimes people feel very different about themselves” | |
|
Appreciate where standard pre‐transplant education may fall short in preparing families for life after transplant Discuss with families the limitations and gaps of pre‐transplant education, particularly with the emotional and psychological aspects after transplant |
|
|
|
| Post Transplant: |
Perform patient and family “check‐ins” regarding the transformation process. Focus not just on laboratory values but also on personal, psychological changes, coping and adjustment Allow time and space to revisit pre‐transplant education and adjust communication strategies for future patients based on this feedback |
|
|
| Continuous: |
|
||
First, it is essential as clinicians to acknowledge and appreciate the nature of the transformative experience itself. In Paul's example of parental decision to have their child undergo or forgo cochlear implantation, “shedding light on the transformative nature of the choice can allow us to cast doubt on how parents can be expected to rationally evaluate these arguments about the subjective value of future experience” [20, p. 47]. In other words, recognizing and respecting transplant as transformative allows us to understand where our pre‐transplant information and education can and likely will fall short in truly preparing families for life post‐transplant.
Second, we must acknowledge that no one can accurately predict what life will look like after transplant for a particular child and family, which requires a degree of epistemic humility that can sometimes be hard to cultivate. As transplant team members we often assume that patients expect us to know everything and to accurately predict their child's kidney health future. Despite our vast knowledge, training and expertise, however, admitting what is unknown or unknowable in a situation can actually help promote honesty and collaboration in medical decision making and signal to families that we can be trusted, both to tell them what we know and what we cannot know with certainty.
Finally, once we as health care professionals acknowledge these gaps, it is important to be open in communicating and acknowledging this information with families. Emphasizing the transformative nature of transplant can help families understand that despite extensive education pre‐transplant or pre‐discharge, there may always be elements of the unknown. Emotionally and psychologically, this can help patients and families understand that those shifts in their perspectives, values and preferences are reasonable and in some ways expected, which may help validate their emotions and experiences. Once we acknowledge, open up space, and allow for patients and families to experience transformation, we as clinicians may then have opportunities along the way to perform post‐transplant “check ins” and discuss the on‐going experience.
6. Opportunities to Support Familial/Patient Autonomy and Decision Making
While acknowledging transplant as transformative can be valuable and help with creating realistic expectations of this new and unknown life post‐transplant, it is important to develop and promote decision making and autonomy for patients and families living with chronic and end stage kidney disease, where options regarding when or whether to transform may be limited. It is therefore important to incorporate established frameworks and strategies which empower and support patient and families throughout the transformation. For example, a shared decision making (SDM) framework is applicable and should be utilized throughout the transplant journey [21]. SDM incorporates both the patient's values and preferences in addition to the clinician's expertise and recommendations, to come to a unified, shared decision [22]. SDM can be implemented when there is more than one medically reasonable option [23], which may often be the case in chronic kidney disease management and pediatric kidney transplant [21]. For example, although pre‐emptive transplant is medically preferable to starting dialysis, transplant timing requires consideration of family and patient input on preferences, values and goals in addition to clinician recommendations. In a case where either transplant or dialysis may be medically reasonable, SDM may be implemented to decide which renal replacement therapy is best at that moment, for that family. Other examples in which shared decision making may be implemented include decisions to seek and/or accept a living donor, whether to participate in a paired exchange program, and whether to accept a deceased donor offer from a less‐than‐ideal donor [21]. Since we've highlighted that a transformative experience may change one's own preferences and values throughout and after the experience itself, reevaluation of goals and preferences begins early, and is continuous throughout the process.
Another means of empowering patients and families throughout a transformative experience is the utilization of Patient and Family Engagement (PFE), defined as “behaviors and actions of children, caregivers, and health care professionals that support active child and caregiver participation in the care of the child and address individual family preferences to positively influence specific child outcomes” [24, 25]. The concept again relies on shared interest in clinical outcomes from both the clinician and family, with personalization and inclusion of a family's values, preferences, unique needs and circumstances. Again, PFE should continually evolve with the patient and family's needs and preferences throughout their transformative experience. Utilization of both SDM and PFE can help empower patients and families throughout their transplant journey. It can also help clinicians with the continual reassessment of values and preferences related to care, which may change significantly throughout this transformative process.
7. Conclusion
Transplant is a transformative experience, but standard discussions of informed consent, and risks and benefits can fall short of acknowledging this reality. Given the life‐changing magnitude of transplant, it is important for clinicians to recognize this transformative process and incorporate this recognition into clinical practice and care. Utilizing frameworks such as Shared Decision Making (SDM) and Patient and Family Engagement (PFE) can help to incorporate and continually reassess the patient and family's values and preferences, and promote both autonomy and collaboration throughout the transformative process of transplant. While discussion here is focused on the transformation of pediatric renal transplant patients, future direction of this work can and should include the journey leading up to transplantation as well as expansion to other solid organ transplants.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
References
- 1. Horslen S., Barr M. L., Christensen L. L., Ettenger R., and Magee J. C., “Pediatric Transplantation in the United States, 1996–2005,” American Journal of Transplantation 7, no. 5 Pt 2 (2007): 1339–1358, 10.1111/j.1600-6143.2007.01780.x. [DOI] [PubMed] [Google Scholar]
- 2. Gillen D. L., Stehman‐Breen C. O., Smith J. M., et al., “Survival Advantage of Pediatric Recipients of a First Kidney Transplant Among Children Awaiting Kidney Transplantation,” American Journal of Transplantation 8, no. 12 (2008): 2600–2606, 10.1111/j.1600-6143.2008.02410.x. [DOI] [PubMed] [Google Scholar]
- 3. American Society of Transplantation , “Pediatric Kidney Transplantation: A Guide for Patients and Families,” (2015), https://www.myast.org/uploads/files/general/Pediatric‐Kidney‐Transplantation‐1‐1.pdf.
- 4. Shellmer D., Brosig C., and Wray J., “The Start of the Transplant Journey: Referral for Pediatric Solid Organ Transplantation,” Pediatric Transplantation 18, no. 2 (2014): 125–133, 10.1111/petr.12215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Hart A., Bruin M., Chu S., Matas A., Partin M. R., and Israni A. K., “Decision Support Needs of Kidney Transplant Candidates Regarding the Deceased Donor Waiting List: A Qualitative Study and Conceptual Framework,” Clinical Transplantation 33, no. 5 (2019): e13530, 10.1111/ctr.13530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Walker R. C., Naicker D., Kara T., and Palmer S. C., “Parents' Perspectives and Experiences of Kidney Transplantation in Children: A Qualitative Interview Study,” Journal of Renal Care 45, no. 3 (2019): 193–200, 10.1111/jorc.12292. [DOI] [PubMed] [Google Scholar]
- 7. Brosig C., Pai A., Fairey E., Krempien J., McBride M., and Lefkowitz D. S., “Child and Family Adjustment Following Pediatric Solid Organ Transplantation: Factors to Consider During the Early Years Post‐Transplant,” Pediatric Transplantation 18, no. 6 (2014): 559–567, 10.1111/petr.12286. [DOI] [PubMed] [Google Scholar]
- 8. Fredericks E. M., Zelikovsky N., Aujoulat I., Hames A., and Wray J., “Post‐Transplant Adjustment—The Later Years,” Pediatric Transplantation 18, no. 7 (2014): 675–688, 10.1111/petr.12366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Bazzano L. A., Durant J., and Brantley P. R., “A Modern History of Informed Consent and the Role of Key Information,” Ochsner Journal 21, no. 1 (2021): 81–85, 10.31486/toj.19.0105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Salgo v Leland Stanford, Jr University Board of Trustees , “154 Cal, App 2d 560, 317 P2d 170,” (1957), https://caselaw.findlaw.com/ca‐court‐of‐appeal/1759823.html.
- 11. Menikoff J., Law and Bioethics: An Introduction (Georgetown University Press, 2006). [Google Scholar]
- 12. Hall D. E., Prochazka A. V., and Fink A. S., “Informed Consent for Clinical Treatment,” Canadian Medical Association Journal 184, no. 5 (2012): 533–540, 10.1503/cmaj.112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Falagas M. E., Korbila I. P., Giannopoulou K. P., Kondilis B. K., and Peppas G., “Informed Consent: How Much and What Do Patients Understand?,” American Journal of Surgery 198, no. 3 (2009): 420–435, 10.1016/j.amjsurg.2009.02.010. [DOI] [PubMed] [Google Scholar]
- 14. Agerskov H., Thiesson H. C., and Pedersen B. D., “Parenting a Child With a Kidney Transplant—A Study of Everyday Life Experiences,” Journal of Renal Care 49 (2023): 134–143, 10.1111/jorc.12410. [DOI] [PubMed] [Google Scholar]
- 15. Dunbar J. C., Bascom E., Pratt W., Snyder J., Smith J. M., and Pollack A. H., “My Kidney Identity: Contextualizing Pediatric Patients and Their Families Kidney Transplant Journeys,” Pediatric Transplantation 26, no. 7 (2022): e14343, 10.1111/petr.14343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Pollack A. H. and Snyder J., “Reflecting on Patient‐Generated Photographs of the Pediatric Renal Transplant Experience,” Pediatric Transplantation 25, no. 3 (2021): e13896, 10.1111/petr.13896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Tong A., Morton R., Howard K., McTaggart S., and Craig J. C., ““When I Had My Transplant, I Became Normal.” Adolescent Perspectives on Life After Kidney Transplantation,” Pediatric Transplantation 15, no. 3 (2011): 285–293, 10.1111/j.1399-3046.2010.01470.x. [DOI] [PubMed] [Google Scholar]
- 18. Ruhl M., Burghall A., Groot B., et al., “Characterizing the Experiences and Educational Needs of Patients and Caregivers During the Kidney Transplant Process,” Canadian Journal of Kidney Health and Disease 12 (2025): 20543581251399080, 10.1177/20543581251399080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Walker R. C., Naicker D., Kara T., and Palmer S. C., “Children's Experiences and Expectations of Kidney Transplantation: A Qualitative Interview Study,” Nephrology (Carlton, Vic.) 24, no. 6 (2019): 647–653, 10.1111/nep.13405. [DOI] [PubMed] [Google Scholar]
- 20. Paul L. A., Transformative Experience (Oxford University Press, 2014). [Google Scholar]
- 21. Gordon E. J., Butt Z., Jensen S. E., et al., “Opportunities for Shared Decision Making in Kidney Transplantation,” American Journal of Transplantation 13, no. 5 (2013): 1149–1158, 10.1111/ajt.12195. [DOI] [PubMed] [Google Scholar]
- 22. Stiggelbout A. M., Van der Weijden T., De Wit M. P., et al., “Shared Decision Making: Really Putting Patients at the Centre of Healthcare,” BMJ 344 (2012): e256, 10.1136/bmj.e256. [DOI] [PubMed] [Google Scholar]
- 23. Whitney S. N., McGuire A. L., and McCullough L. B., “A Typology of Shared Decision Making, Informed Consent, and Simple Consent,” Annals of Internal Medicine 140, no. 1 (2004): 54–59, 10.7326/0003-4819-140-1-200401060-00012. [DOI] [PubMed] [Google Scholar]
- 24. Jerofke‐Owen T. A., McAndrew N. S., Gralton K. S., et al., “Engagement of Families in the Care of Hospitalized Pediatric Patients: A Scoping Review,” Journal of Family Nursing 28, no. 2 (2021): 151–171, 10.1177/10748407211048894. [DOI] [PubMed] [Google Scholar]
- 25. House T. R., Helm K., and Wightman A., “Building Partnerships to Improve Health Outcomes: Pediatric Patient and Family Engagement in Nephrology Practice,” Advances in Kidney Disease and Health 31, no. 1 (2024): 37–45, 10.1053/j.akdh.2023.10.003. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
